Public Company News

Clinical Trial Approval For mRNA Covid-19 Vaccine For Omicron Variant In The Philippines

TAIZHOU, China, June 27, 2022 /PRNewswire/ -- Jiangsu Recbio Technology Co., Ltd. is pleased to announce that, the Group has recently received the clinical trial approval (the"Clinical Trial Approval") for its R520A, a mRNA COVID-19 vaccine ("R520A"), from the Food and Drug Administration ofthe P...

2022-06-27 14:47 4653

Yidu Tech Announces Annual Results for Fiscal Year 2022

HONG KONG, June 27, 2022 /PRNewswire/ -- Yidu Tech Inc. ("Yidu Tech", the "Group", HKEx: 2158), a leading company inChina's healthcare intelligence industry, announced its annual results for the fiscal year endedMarch 31, 2022 ("FY2022" or the "Reporting Period"). During the Reporting Period, the...

2022-06-27 14:44 3917

Abcam: Appointment of Vice President of Investor Relations

CAMBRIDGE, England, June 27, 2022 /PRNewswire/ -- Abcam  plc ("Abcam," "Company," "Group") (AIM: ABC) (Nasdaq: ABCM), a global leader in the supply of life science research tools, today announces the appointment ofTommy Thomas as Vice President of Investor Relations...

2022-06-27 14:00 4068

ESR successfully completes 520,000 sqm of Class A, 100% pre-leased logistics warehouse space in South Korea within first half of 2022

Cementing ESR's leadership as the largest logistics owner in the country SEOUL, South Korea, June 27, 2022 /PRNewswire/ -- ESR Group Limited ("ESR" or the "Group"; SEHK Stock Code: 1821), APAC's largest real asset manager powered by the New Economy, today announced that ESR-Kendall Square, ESR's ...

2022-06-27 13:54 4466

Fosun International Places Third in "Best ESG" at Institutional Investor's "2022 All-Asia Executive Team" Rankings

HONG KONG, June 27, 2022 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International") received Institutional Investor's notice  on 23 June that Fosun International achieved third place in "Best ESG" (buy-side) at Institutional Investor's "2022 All-Asia Executive Tea...

2022-06-27 13:30 3393

LIXIL announces winners and continuing support of the Asia Pacific Property Awards 2022-23

LIXIL's GROHE and American Standard brands celebrate industry excellence at the International Property Awards and reaffirm support with signing of new three-year sponsorship SINGAPORE, June 27, 2022 /PRNewswire/ -- LIXIL, maker of pioneering water and housing products, announced the winners of t...

2022-06-27 12:30 4890

Hisense Praises Women Football Players through #RememberTheName Campaign, Commits to Enhancing Tournament Experience

QINGDAO, China, June 27, 2022 /PRNewswire/ -- Across the past year, many football fans' attention has been drawn to women's football worldwide. As the proud partner of UEFA Women's EURO 2022™, Hisense aims to contribute to the substantial growth and professionalization of women's football, inspir...

2022-06-27 10:41 4851

Antengene Announces Clinical Trial Collaboration with BeiGene to Evaluate Selinexor in Combination with Tislelizumab in T and NK-Cell Lymphoma

-    Selinexor is an oral small molecule XPO1 inhibitor; tislelizumab is an anti-PD-1 checkpoint inhibitor SHANGHAI and HONG KONG, June 27, 2022 /PRNewswire/ -- Antengene Corporation Limited ("Antengene" SEHK: 6996.HK), a leading innovative, commercial-stage global biopharmaceutical company dedi...

2022-06-27 08:30 3664

Ascletis' Subcutaneous PD-L1 Antibody ASC22 Demonstrated Potential of Functional Cure of Chronic Hepatitis B as 42.9% of Patients with Baseline HBsAg≤100 IU/mL Obtained Sustained HBsAg Loss

--Ascletis presented Phase IIb clinical trial results of subcutaneous PD-L1 antibody ASC22 for functional cure of CHB at oral session of EASL ILC 2022 on June 25, 2022, Beijing Time --The Phase IIb clinical trial results further demonstrated the potential of ASC22+NAs treatment as a functional cu...

2022-06-27 08:11 4010

Innovent and Lilly Jointly Announce the Approval of TYVYT® (sintilimab injection) by China NMPA in Combination with Chemotherapy as First-line Treatment of Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

SAN FRANCISCO and SUZHOU, China, June 27, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of cancer, autoimmune, metabolic, ophthalmology and o...

2022-06-27 08:00 4944

Shanghai Electric's Offshore Wind Turbine Generator Designed for China's Climate Rolls off Production Line

SHANGHAI, June 24, 2022 /PRNewswire/ -- Shanghai Electric Wind Power Group Co., Ltd.' s (Shanghai Electric) first EW8.X-230 wind turbine generator rolled off the production line at the Putian manufacturing facility onJune 10, representing a n...

2022-06-24 22:10 12798

Yili Remains the Most Chosen FMCG Brand in China, according to Kantar's Brand Footprint Report 2022

HOHHOT, China , June 24, 2022 /PRNewswire/ -- On June 23, Kantar Worldpanel released itsChinese Mainland Brand Footprint Report 2022. With a 92.4% brand penetration rate and a consumer reach of 1.3 billion, Yili was once again ranked first among the most chosen FMCG brands in the Chinese market. ...

2022-06-24 20:18 6747

ATEN MicLIVE(TM) Wins 2022 Best of InfoComm Award

ATEN's MicLIVE™ Podcast AI Audio Mixer Honored in AV Technology Category NEW TAIPEI CITY, Taiwan, June 24, 2022 /PRNewswire/ -- ATEN International, the leading provider of KVM and AV/IT connectivity and management solutions, today announces its MicLIVE™ Podcast AI Audio Mixer was awarded a 2022 B...

2022-06-24 19:08 3405

Zoomlion Carries Forward Its International Market Development with Localization Strategy and Diversified Logistics

CHANGSHA, CHINA, June 24, 2022 /PRNewswire/ -- Zoomlion Heavy Industry Science & Technology Co., Ltd. ("Zoomlion"; 1157.HK), a leading high-end equipment manufacturing enterprise, has reported a 51.05 percent year-on-year growth of overseas sales in 2021, further expanding its business developmen...

2022-06-24 17:10 4808

Sungrow Ranks No. 1 in 2021 Global PV Inverter Shipment, Estimated by IHS Markit now a part of S&P Global

HEFEI, China, June 24, 2022 /PRNewswire/ -- International authoritative research institution IHS Markit (now a part of S&P Global) announced the top 10 global PV inverter companies in terms of estimated shipments in 2021. Sungrow, with 47.1 GWac inverter shipments, becomes the No.1 PV inverter su...

2022-06-24 16:48 3826

New World Development Announces Approval of Near-Term 1.5°C Aligned Science Based Targets and Commitment to Net-Zero

HONG KONG, June 24, 2022 /PRNewswire/ -- New World Development Company Limited ("NWD", the "Company" or the "Group",Hong Kong stock code: 00017) announced today that the Company has become the third real estate developer inAsia to receive the Science Based Targets initiative's (SBTi) approval of ...

2022-06-24 13:28 4171

Sims Metal Hires Robert Thompson as Chief Commercial Officer

– Global responsibility for material buying and sales, key member of executive team –  NEW YORK, June 24, 2022 /PRNewswire/ -- Sims Metal, a global leader in metal recycling and a division of Sims Limited, announces the appointment ofRobert Thompson as its Global Chief Commercial Officer. Mr. Th...

2022-06-24 12:25 4288

Fosun International received S&P Global Rating's latest report

Fosun has flexibility to replenish cash and has adequate resources to manage debt maturities HONG KONG, June 24, 2022 /PRNewswire/ -- Fosun International Limited (HKEX stock code: 00656, "Fosun International") received S&P Global Rating's latest report published yesterday, where it points out th...

2022-06-24 11:10 4884

MONEYME launches ListReady direct to consumers to further empower sellers

SYDNEY, June 24, 2022 /PRNewswire/ -- Digital lender and non-bank challenger MONEYME  (ASX: MME) is expanding its ListReady  product in a bid to further empower sellers in a shifting property market. The popular payment solution f...

2022-06-24 09:45 4043

Novavax COVID-19 Vaccine Nuvaxovid™ Recommended for Expanded Conditional Marketing Authorization in the European Union by CHMP for Adolescents Aged 12 Through 17

* Upon authorization, Nuvaxovid™ would be the first protein-based option for adolescents aged 12 through 17 inEurope * Nuvaxovid™ demonstrated 80% efficacy and was generally well-tolerated in adolescents GAITHERSBURG, Md., June 24, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechn...

2022-06-24 03:24 5362
1 ... 737738739740741742743 ... 901